Smart multi-target drugs are reshaping modern therapeutics by addressing the complex, interconnected pathways that drive diseases like Alzheimer’s, cancer, and major depressive disorder. Advances in ...
Investments in R&D have grown dramatically since 1950, but the number of newly approved drugs has only recently begun to increase. According to a 2018 Deloitte report, returns on research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback